Calendar

Allstate has a confirmed November 4 after-market earnings announcement, consensus of $6.89 EPS and $15.84B revenue, and a reported EPS beat in 7 of its last 8 quarters; however, consensus implies year-over-year EPS and revenue declines, the stock fell about 3.4% over five sessions, recent closes were weak within their daily ranges, and no positive estimate revisions or volume surge were verified.

MetLife has a confirmed November 4 after-market release and published consensus of $2.77 EPS and $19.86B revenue, with prior-quarter EPS above consensus and positive Q3 expected EPS growth; however, checked sources did not establish positive current-quarter estimate revisions, ESP/whisper upside, or revenue estimate increases, and the recent tape weakened without verified volume accumulation.

Aflac shares have advanced over the recent weeks, but checked Q3 consensus implies lower year-over-year EPS and revenue and no positive estimate-revision or revenue-upside signal was found; the latest session also lacked a qualifying close location.

Edwards has a November 4 earnings date and published Q3 consensus of $0.74 EPS and $1.68B revenue, with a prior-quarter EPS beat and evidence of ongoing product-market growth; the checked sources do not establish positive estimate revisions or revenue upside, and recent volume was not verified at the required threshold.

The company confirmed a Nov 4 after-close Q3 release, and available sources show EPS and revenue consensus estimates. However, no positive estimate revisions or revenue upside evidence was found; VMRK fell 1.6% over five sessions, underperformed the S&P 500, and Oct 28 volume was below normal. Merger integration is a disclosed risk, so this is not a qualifying surprise setup.

MercadoLibre's latest reported quarter showed strong revenue acceleration, but the checked pre-event sources do not establish positive EPS revisions/ESP or revenue revisions/upside; the stock also fell sharply during the recent tape window, with the highest-volume session a selloff. Those shortcomings outweigh the longer-term operating growth story.

The initial reaction was negative: [shares were reported down 5.8% premarket on October 20](https://finance.yahoo.com/markets/stocks/articles/steel-dynamics-shares-fall-5-103343450.html). The packet's October 21 anchor of $247.97 is above the [$245.17 October 19 close](https://www.financialcontent.com/quote/NQ:STLD/historical), suggesting the initial decline did not persist through that anchor, although a verified October 20 closing-price series is unavailable. Post-print analyst evidence is mixed rather than uniformly negative: Wells Fargo raised its target and Goldman Sachs reportedly reiterated Buy. The deterministic delta prior turned negative with a 0.685 thesis-change score; strong primary evidence improves confidence in what happened, not in how durable steel spreads will be. Social, options, short-interest, and employee measures were not supplied; zero placeholders above indicate unavailable data, not neutral readings.

The October 21 anchor of $113.20 was about 2.3% below the October 20 close of $115.90, although that move cannot be attributed solely to the sales release. [IPAR historical prices](https://chartexchange.com/symbol/nasdaq-ipar/historical/) The Q3 print is mixed: stronger European brands offset weaker U.S. operations, and full earnings are still pending. A dated target-history page shows no consensus-target change through October 21, but no reliable individual post-print revision was confirmed. [Analyst target history](https://www.chartmill.com/stock/quote/IPAR/analyst-ratings) The stored earnings-document row concerns Cintas, not IPAR, and was excluded.

The release produced a clear negative initial reaction: HBCP fell 9.59% on October 20, from $65.78 to $59.47, then closed October 21 at the packet's $59.80 anchor, a modest rebound ([historical prices](https://ph.investing.com/equities/home-bancorp-historical-data)). The miss and credit migration support a cautious tone despite the deterministic prior's positive directional score. No reliable post-print target or estimate revision was confirmed; thin coverage limits confidence. Social, options and employee sentiment were not evidenced, and their numeric placeholders should not be interpreted as measured neutrality.

The scheduled follow-up cites an October 19 earnings date, but the company issued its Q3 release on October 21. As of this October 22 review, a verified post-release regular-session price reaction and post-print analyst revisions were unavailable; the $44.33 anchor should not be treated as either. The earnings miss worsens the prior neutral monitoring thesis, although the deterministic prior remains neutral and the acquired deposit base offers a possible offset. Social coverage is absent, and the numerical sentiment fields other than news tone are unavailable rather than measured zero.

The initial reaction was favorable: FNB rose 4.13% on October 20 after the release and another 0.79% on October 21, closing at the packet's $17.80 anchor. That recovery does not erase the revenue miss or Raymond James's subsequent target cut. No verified post-print estimate-revision series or guidance change was found, so this T+3 update improves the evidence base and near-term tone without establishing a durable rerating. [Price history](https://stockanalysis.com/stocks/fnb/history/); [analyst revision](https://www.tipranks.com/news/the-fly/f-n-b-price-target-lowered-to-20-from-21-at-raymond-james-thefly-news).

The post-print reaction was volatile rather than a clean endorsement: shares opened October 20 at $106.09 versus the $114.89 pre-release close, recovered to close at $114.17, then closed October 21 at the $116.22 anchor. The reported weak Q4 consensus comparison weighed on early trading, while October 21 analyst target raises were small. Broad forward-estimate revisions are not established. Social, options, short-interest and employee readings are unavailable; zeros above are placeholders, not measurements. [Price history](https://chartexchange.com/symbol/nyse-cck/historical/) [Market reaction](https://ng.investing.com/news/stock-market-news/why-is-crown-stock-sliding-today-93CH-2745126) [Analyst actions](https://www.benzinga.com/quote/CCK/price-targets)